Zevra Therapeutics (ZVRA) Shares Outstanding (Entity) (2014 - 2026)
Zevra Therapeutics (ZVRA) posted Shares Outstanding (Entity) of 59.34 million for Q2 2026, up 7.7% from 55.08 million a year earlier and up 0.4% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Shares Outstanding (Entity) (2014 - 2026) Analysis & Trends
For FY2025, Zevra Therapeutics' Shares Outstanding (Entity) came in at 56.85 million, up 5.9% from FY2024.
- Annual Shares Outstanding (Entity) has increased for three consecutive years, with a five-year compound annual growth rate of 44.3% (FY2020 to FY2025).
- In prior years, Zevra Therapeutics' Shares Outstanding (Entity) was 53.67 million in FY2024 (+29.2%), 41.53 million in FY2023 (+20.2%), 34.54 million in FY2022 (-50.7%) and 70.01 million in FY2021 (+671.5%).
- The Q2 2026 figure stands as the highest quarterly Shares Outstanding (Entity) since Q3 2022.
- On a year-over-year basis, Shares Outstanding (Entity) has increased in each of the last 11 quarters, with growth averaging 20.7% over the last eight quarters.
- The strongest year-over-year quarter for Shares Outstanding (Entity) in the past five years was Q3 2021, with growth of 679.3%; the weakest was Q2 2023, with a decline of 50.8%.
- According to Business Quant data, Shares Outstanding (Entity) for the three prior quarters was 59.11 million (Q1 2026), 56.85 million (Q4 2025) and 56.22 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Zevra Therapeutics | 650.98 Mn | -161.73 Mn | 38.18 Mn | 59.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.34 Mn |
| Mar 31, 2026 | 59.11 Mn |
| Dec 31, 2025 | 56.85 Mn |
| Sep 30, 2025 | 56.22 Mn |
| Jun 30, 2025 | 55.08 Mn |
| Mar 31, 2025 | 54.68 Mn |
| Dec 31, 2024 | 53.67 Mn |
| Sep 30, 2024 | 53.23 Mn |
| Jun 30, 2024 | 41.99 Mn |
| Mar 31, 2024 | 41.85 Mn |
| Dec 31, 2023 | 41.53 Mn |
| Sep 30, 2023 | 36.21 Mn |
| Jun 30, 2023 | 33.93 Mn |
| Mar 31, 2023 | 33.88 Mn |
| Dec 31, 2022 | 34.54 Mn |
| Sep 30, 2022 | 69.00 Mn |
| Jun 30, 2022 | 68.98 Mn |
| Mar 31, 2022 | 68.85 Mn |
| Dec 31, 2021 | 70.01 Mn |
| Sep 30, 2021 | 70.63 Mn |
API Access
Zevra Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();